Related Experiment Video
Updated: Jul 29, 2025

High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
Published on: June 16, 2018
Abstract:
The goal of PrecisionTox is to overcome conceptual barriers to replacing traditional mammalian chemical safety testing by accelerating the discovery of evolutionarily conserved toxicity pathways that are shared by descent among humans and more distantly related animals. An international consortium is systematically testing the toxicological effects of a diverse set of chemicals on a suite of five model species comprising fruit flies, nematodes, water fleas, and embryos of clawed frogs and zebrafish along with human cell lines. Multiple forms of omics and comparative toxicology data are integrated to map the evolutionary origins of biomolecular interactions that are predictive of adverse health effects, to major branches of the animal phylogeny. These conserved elements of adverse outcome pathways (AOPs) and their biomarkers are expected to provide mechanistic insight useful for regulating groups of chemicals based on their shared modes of action. PrecisionTox also aims to quantify risk variation within populations by recognizing susceptibility as a heritable trait that varies with genetic diversity. This initiative incorporates legal experts and collaborates with risk managers to address specific needs within European chemicals legislation, including the uptake of new approach methodologies (NAMs) for setting precise regulatory limits on toxic chemicals.
Insights
PrecisionTox accelerates chemical safety testing by identifying conserved toxicity pathways across species. This approach aids in replacing animal testing and understanding human health risks from toxic chemicals.
Area of Science:
- Comparative toxicology
- Evolutionary biology
- Genomics
Background:
- Traditional mammalian chemical safety testing faces limitations.
- PrecisionTox aims to replace these methods by identifying conserved toxicity pathways.
- Utilizes five model species (invertebrates, amphibians, fish) and human cell lines for broad applicability.
Discussion:
- Integrates omics and comparative toxicology data to map evolutionary origins of toxicity pathways.
- Identifies conserved elements of adverse outcome pathways (AOPs) and biomarkers.
- Focuses on shared modes of action for regulating chemical groups.
Key Insights:
- Discovers evolutionarily conserved toxicity pathways shared across diverse animal species and humans.
- Establishes biomarkers predictive of adverse health effects.
- Quantifies population risk variation based on genetic diversity and susceptibility as a heritable trait.
Outlook:
- Provides mechanistic insights for regulating chemical groups based on shared modes of action.
- Supports the uptake of new approach methodologies (NAMs) in regulatory frameworks.
- Aims to set precise regulatory limits for toxic chemicals within European legislation.

